Cargando…
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II
Diabetes is a complex disease characterized by hyperglycemia, together with polyuria, polydipsia, and polyphagia. While Type 1 diabetes mellitus (T1DM) results from genetic, environmental, or immune dysfunction factors leading to pancreatic β-cell destruction depriving the organism from endogenous i...
Autores principales: | Vieira, Raquel, Souto, Selma B., Sánchez-López, Elena, López Machado, Ana, Severino, Patricia, Jose, Sajan, Santini, Antonello, Silva, Amelia M., Fortuna, Ana, García, Maria Luisa, Souto, Eliana B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780268/ https://www.ncbi.nlm.nih.gov/pubmed/31466386 http://dx.doi.org/10.3390/jcm8091332 |
Ejemplares similares
-
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I
por: Vieira, Raquel, et al.
Publicado: (2019) -
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity
por: Vieira, Raquel, et al.
Publicado: (2020) -
The Nutraceutical Value of Carnitine and Its Use in Dietary Supplements
por: Durazzo, Alessandra, et al.
Publicado: (2020) -
Ocular Cell Lines and Genotoxicity Assessment
por: Souto, Eliana B., et al.
Publicado: (2020) -
(+)-Limonene 1,2-Epoxide-Loaded SLNs: Evaluation of Drug Release, Antioxidant Activity, and Cytotoxicity in an HaCaT Cell Line
por: Souto, Eliana B., et al.
Publicado: (2020)